These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33583369)

  • 1. Ultrasound-Triggered Immunotherapy for Cancer Treatment: An Update.
    Mukhopadhyay D; Ahmed A; Sano C; Awad N; Al Sawaftah N; Husseini GA
    Curr Protein Pept Sci; 2021; 22(6):493-504. PubMed ID: 33583369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
    Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
    Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Immunoliposome Technology for Enhancing the Activity of the Agonistic Antibody against the Tumor Necrosis Factor Receptor Superfamily.
    Niwa T; Kasuya Y; Suzuki Y; Ichikawa K; Yoshida H; Kurimoto A; Tanaka K; Morita K
    Mol Pharm; 2018 Sep; 15(9):3729-3740. PubMed ID: 29648839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers.
    Yan F; Li L; Deng Z; Jin Q; Chen J; Yang W; Yeh CK; Wu J; Shandas R; Liu X; Zheng H
    J Control Release; 2013 Mar; 166(3):246-55. PubMed ID: 23306023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: In vitro and in vivo studies.
    Nikpoor AR; Tavakkol-Afshari J; Sadri K; Jalali SA; Jaafari MR
    Nanomedicine; 2017 Nov; 13(8):2671-2682. PubMed ID: 28847682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibody-dependent cellular cytotoxicity in the immunotherapeutic mechanisms of anti-EGFR monoclonal antibody].
    Shimodaira H; Komine K; Soeda H; Ishioka C
    Gan To Kagaku Ryoho; 2010 May; 37(5):795-8. PubMed ID: 20495309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved.
    Lentacker I; Geers B; Demeester J; De Smedt SC; Sanders NN
    Mol Ther; 2010 Jan; 18(1):101-8. PubMed ID: 19623162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues.
    Ingram N; McVeigh LE; Abou-Saleh RH; Maynard J; Peyman SA; McLaughlan JR; Fairclough M; Marston G; Valleley EMA; Jimenez-Macias JL; Charalambous A; Townley W; Haddrick M; Wierzbicki A; Wright A; Volpato M; Simpson PB; Treanor DE; Thomson NH; Loadman PM; Bushby RJ; Johnson BRG; Jones PF; Evans JA; Freear S; Markham AF; Evans SD; Coletta PL
    Theranostics; 2020; 10(24):10973-10992. PubMed ID: 33042265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-Triggered Drug Delivery for Breast Tumor Therapy Through iRGD-Targeted Paclitaxel-Loaded Liposome-Microbubble Complexes.
    Zhang J; Wang S; Deng Z; Li L; Tan G; Liu X; Zheng H; Yan F
    J Biomed Nanotechnol; 2018 Aug; 14(8):1384-1395. PubMed ID: 29903054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy.
    Narayanaswamy R; Torchilin VP
    Pharm Res; 2021 Mar; 38(3):429-450. PubMed ID: 33655395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoliposomes: A review on functionalization strategies and targets for drug delivery.
    Eloy JO; Petrilli R; Trevizan LNF; Chorilli M
    Colloids Surf B Biointerfaces; 2017 Nov; 159():454-467. PubMed ID: 28837895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo.
    Shi C; Cao H; He W; Gao F; Liu Y; Yin L
    Biomed Pharmacother; 2015 Jul; 73():48-57. PubMed ID: 26211582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor targeting using anti-her2 immunoliposomes.
    Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
    J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational Prospects of ultrasound-mediated tumor immunotherapy: Preclinical advances and safety considerations.
    Xu W; Zhang X; Hu X; Zhiyi C; Huang P
    Cancer Lett; 2019 Sep; 460():86-95. PubMed ID: 31254552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future directions of liposome- and immunoliposome-based cancer therapeutics.
    Park JW; Benz CC; Martin FJ
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical translation of immunoliposomes for cancer therapy: recent perspectives.
    Wang D; Sun Y; Liu Y; Meng F; Lee RJ
    Expert Opin Drug Deliv; 2018 Sep; 15(9):893-903. PubMed ID: 30169978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cytotoxicity, immunostimulatory and antitumor effects of lipid content of liposomal delivery platforms in cancer immunotherapies. A comprehensive in-vivo and in-vitro study.
    Nikpoor AR; Jaafari MR; Zamani P; Teymouri M; Gouklani H; Saburi E; Darban SA; Badiee A; Bahramifar A; Fasihi-Ramandi M; Taheri RA
    Int J Pharm; 2019 Aug; 567():118492. PubMed ID: 31271815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes.
    Koning GA; Kamps JA; Scherphof GL
    Cancer Detect Prev; 2002; 26(4):299-307. PubMed ID: 12430634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model.
    Merino M; Lozano T; Casares N; Lana H; Troconiz IF; Ten Hagen TLM; Kochan G; Berraondo P; Zalba S; Garrido MJ
    J Nanobiotechnology; 2021 Apr; 19(1):102. PubMed ID: 33849551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.